BioSpace News Archive

Magenta Therapeutics, Inc. announced the pricing of its public offering of 4,250,000 shares of its common stock at a price to the public of $13.25 per share, for total gross proceeds of approximately $56.3 million.

The 124 registered nurses at Steward Nashoba Valley Medical Center in Ayer, who are represented by the Massachusetts Nurses Association and who are currently in contract talks with management, cast an overwhelming vote this week authorizing their local union leaders to call a one-day strike should hospital management fail to address several issues that currently affect RNs’ ability to deliver the best possible care to their patients.

Bristol-Myers Squibb Company announced that the requisite number of consents have been received to adopt proposed amendments with respect to all outstanding notes of Celgene Corporation.

CStone Pharmaceuticals and Numab Therapeutics AG announce that they have entered into an exclusive regional licensing agreement for the development and commercialization of ND021, a potential best-in-class monovalent, tri-specific antibody-based molecule targeting PD-L1, 4-1BB, and human serum albumin.

UndergroundStocks.com, an elite wall street independent small cap media group with a history of bringing lucrative opportunities, Reports on Omni Health, Inc.

Following the capital increase and listing on Nasdaq, cash and cash equivalents totaled €314.1 million as of March 31, 2019

Biom’up announced its full-year results for the year ending December 31, 2018, as approved by the Company’s Board of Directors on April 29, 2019, and provided an update on its operations.

Recipharm AB will publish its interim report for January-March 2019 on 3 May at 07:45 am CET.

System Offers New Options for Improving Outcomes in Treating Stroke

Codexis’ breakthrough enzyme cascade system enables better-tasting stevia product launch